A recent study from the CDC found a nearly 70% increase in the spread of carbapenem-resistant Enterobacterales (CRE).
Despite rapid advances in reading the genetic code of living organisms, scientists still face a major challenge today—knowing ...
When you buy through links on our articles, Future and its syndication partners may earn a commission.
A new report from the CDC reveals that infection rates for a drug-resistant “nightmare bacteria” are on the rise, increasing ...
California is battling a deadly drug-resistant fungus at the same time a 'nightmare bacteria' is surging nationwide.
The first participant in an investigational gene therapy trial of STXBP1 encephalopathy died, Capsida Biotherapeutics said. The death occurred days after dosing, according to information posted on the ...
Infection rates for a drug-resistant "nightmare bacteria" are rising, per a new report from the CDC. Why it matters: ...
A concerning report from the CDC reveals a significant surge in drug-resistant \"nightmare bacteria\" infections across the ...
CRE 360 Partners' site selection and deal services have become a trusted resource for brands growing nationwide. National athletic retailer: Secured 13 opportunities in one state this year, making CRE ...
The infection rate of one type of carbapenem-resistant Enterobacterales bacteria has risen by more than 460 percent in recent ...
Infections tied to the NDM gene have grown more than fivefold since 2019, leaving only two expensive drugs as treatment options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results